Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women

PHASE3CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2012

Study Completion Date

October 31, 2012

Conditions
Menopausal SyndromeAtherosclerosis
Interventions
DIETARY_SUPPLEMENT

Karinat

DRUG

Placebo

Sugar pill manufactured to mimic Karinat 500 mg tablet

All Listed Sponsors
lead

Institute for Atherosclerosis Research, Russia

OTHER

NCT01741974 - Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women | Biotech Hunter | Biotech Hunter